Evidence map›Paper›PMID 35925609›Full record

ArticleAdvanced biology2022

Schwann Cells Induce Phenotypic Changes in Oral Cancer Cells.

Maria Daniela Santi, Morgan Zhang, Elizabeth Salvo, Kesava Asam, Chi T Viet, Tongxin Xie, Moran Amit, Bradley Aouizerat, Yi Ye

Open access · greenAbstract read
In one paragraph

Article in Advanced biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Maria Daniela SantiBluestone Center for Clinical Research, College of Dentistry, New York University, New York, NY, 10012, USA.
Morgan ZhangBluestone Center for Clinical Research, College of Dentistry, New York University, New York, NY, 10012, USA.
Elizabeth SalvoBluestone Center for Clinical Research, College of Dentistry, New York University, New York, NY, 10012, USA.
Kesava AsamBluestone Center for Clinical Research, College of Dentistry, New York University, New York, NY, 10012, USA.
Chi T VietLoma Linda University School of Dentistry, Loma Linda, CA, 92350, USA.
Tongxin XieHead & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Moran AmitHead & Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Bradley AouizeratBluestone Center for Clinical Research, College of Dentistry, New York University, New York, NY, 10012, USA.
Yi YeBluestone Center for Clinical Research, College of Dentistry, New York University, New York, NY, 10012, USA.ORCID 0000-0002-1075-5584
Center for Clinical Research (United States) · USThe University of Texas MD Anderson Cancer Center · USLoma Linda University · US

Funding

The REASON Score: An Epigenetic And Clinicopathologic Score to Predict Risk of Poor Survival in Early Stage Oral Squamous Cell Carcinoma PatientsR01DE031395 · NIDCR · LOMA LINDA UNIVERSITY · PI Chi T. Viet · 2022 to 2026
$3.7M
Schwann cell activation in oral cancer perineurial invasion and neuropathic painR01DE029493 · NIDCR · NEW YORK UNIVERSITY · PI YE, YI · 2020 to 2024
$2.2M
Clinical study to evaluate the methylation signature of head and neck squamous cell carcinoma painK23DE030250 · NIDCR · LOMA LINDA UNIVERSITY · PI VIET, CHI T. · 2021 to 2025
$865k
Schwann Cell Activation and Oral Cancer PainR03DE027777 · NIDCR · NEW YORK UNIVERSITY · PI YE, YI · 2018 to 2019
$317k
NIDCR NIH HHS K23 DE030250NIDCR NIH HHS R01 DE029493NIDCR NIH HHS R01 DE031395NIDCR NIH HHS R03 DE027777
6 · The paper itself

Abstract

Head and neck cancer (HNC) is the seventh most common cancer worldwide, the majority being oral squamous cell carcinoma. Despite advances in cancer diagnosis and treatment, the survival rate of patients with HNC remains stagnant. The cancer-nerve interaction has been recognized as an important driver of cancer progression. Schwann cells, a type of peripheral glia, have been implicated in promoting cancer cell growth, migration, dispersion, and invasion into the nerve in many cancers. Here, it is demonstrated that the presence of Schwann cells makes oral cancer cells more aggressive by promoting their proliferation, extracellular matrix breakdown, and altering cell metabolism. Furthermore, oral cancer cells became larger, more circular, with more projections and nuclei following co-culturing with Schwann cells. RNA-sequencing analysis in oral cancer cells following exposure to Schwann cells shows corresponding changes in genes involved in the hallmarks of cancer and cell metabolism; the enriched KEGG pathways are spliceosome, RNA transport, cell cycle, axon guidance, signaling pathways regulating pluripotency of stem cells, cAMP signaling, WNT signaling, proteoglycans in cancer and PI3K-Akt signaling. Taken together, these results suggest a significant role for Schwann cells in facilitating oral cancer progression, highlighting their potential as a target to treat oral cancer progression.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsMouth NeoplasmsCell ProliferationHumansPhosphatidylinositol 3-KinasesSchwann CellsWnt Signaling Pathwayinvasionmetabolismmetastasisoral squamous cell carcinomaperineural invasionproliferationSchwann cells

Identifiers

PMID35925609
PMCPMC9474679
OpenAlexW4289778752

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.